Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Gross Profit

Alexion Pharm Inc Gross Profit Chart (ALXN)

Alexion Pharm Inc annual/quarterly Gross Profit from 2010 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Alexion Pharm Inc Gross Profit for the quarter ending September 09, 2020 was $1,444m a 12.05% increase of 174m year over year
  • Alexion Pharm Inc Gross Profit for the last 12 months ending September 09, 2020 was $5,347m a 14.03% increase of 750m year over year
  • Alexion Pharm Inc Annual Gross Profit for 2019 was $4,597m a 18.14% increase of 834m from 2018
  • Alexion Pharm Inc Annual Gross Profit for 2018 was $3,763m a 13.65% increase of 514m from 2017
  • Alexion Pharm Inc Annual Gross Profit for 2017 was $3,249m a 13.03% increase of 423m from 2016
Other Income Statement Metrics:
  • Alexion Pharm Inc EBITDA for the quarter ending December 12, 2018 was $533m a 18.12% increase of 97m year over year
  • Alexion Pharm Inc Net Income for the quarter ending December 12, 2018 was $-45m a 653.56% decrease of -294m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Gross Profit Data

09/2020$1,444m
06/2020$1,300m
03/2020$1,333m
12/2019$1,270m
09/2019$1,168m
06/2019$1,104m
03/2019$1,055m
12/2018$1,032m
09/2018$936m
06/2018$950m

Annual ALXN Gross Profit Data

2019$4,597m
2018$3,763m
2017$3,249m
2016$2,826m
2015$2,371m
2014$2,060m
2013$1,383m
2012$1,008m
2011$690m
2010$477m